Menu Back to CMC-Workshop-From-Drug-Development-to-Global-Supply-to-Patients

Program Committee

  • Yasmin  de Faria Krim, PharmD, MSc
    Yasmin de Faria Krim, PharmD, MSc
    Chair DIA CMC Working Group - Regulatory Affairs Community, France
  • Lin-Jau (Christine) Wu Anderson, MS, RAC
    Lin-Jau (Christine) Wu Anderson, MS, RAC Senior Research Scientist, Global Regulatory, Chemistry, Manufacturing & Control
    Eli Lilly and Company, US, United States
  • Nagesh  Bandi, PhD
    Nagesh Bandi, PhD Director, Global CMC
    Pfizer Pharmaceuticals, Inc., United States
  • Ganapathy  Mohan, PhD
    Ganapathy Mohan, PhD Head of Global CMC
    Merck & Co., Inc., United States
  • Elaine  Morefield, PhD, RPh
    Elaine Morefield, PhD, RPh Vice President, Regulatory Affairs
    VaxForm, LLC., United States
  • Peter  Richardson, PhD
    Peter Richardson, PhD Head of Quality, Human Medicines R&D Support Division
    European Medicines Agency, European Union, United Kingdom
  • Jean-Louis  Robert, PhD
    Jean-Louis Robert, PhD CHMP (EMA) Co-Opted Member / CHMP (EMA) QWP Chair
    CHMP (European Medicines Agency), Luxembourg
  • Thirunellai G Venkateshwaran, PhD
    Thirunellai G Venkateshwaran, PhD Senior Director and Global Head, Product Management - Marketed Products
    Hoffman La Roche Ltd., Switzerland
Load More